Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, July 29, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Syrris to Launch Asia Flux Electrochemistry Module at IMRET 2014
Thursday, June 12, 2014
International Conferences on Microreaction Technology in Budapest, Hungary, from the 23rd to the 25th of June 2014.

Process Reliability Guide Released from Mettler Toledo
Wednesday, June 11, 2014
New guide on increasing process reliability with "Intelligent" Sensors.

Odour Free Evaporation on Users Lab Bench
Wednesday, June 04, 2014
“Odour Reduction” function for Genevac’s EZ-2 evaporator.

Higher Performance from Vacuum Jacketed Reactor System
Wednesday, June 04, 2014
Asynt’s ReactoMate Reactor System provides excellent reaction visibility and reduces condensation.

Sartorius Stedim Biotech Launches New Single-Use Bag Family Flexsafe
Tuesday, June 03, 2014
Innovative polyethylene film sets new benchmark.

New Temperature Control Catalogue 2014/2015
Tuesday, June 03, 2014
New catalogue from Huber presents high precision thermoregulation solutions for laboratories, pilot plants and production processes.

Syrris Offers Fully Automated Pressure Reactors
Friday, May 30, 2014
Atlas Potassium Pressure System - Designed specifically for high vacuum processes.

New Undergrad Hotplate Stirrers from Stuart
Saturday, May 24, 2014
New models deliver upmost levels of control and accuracy.

New Webinar on How to Accelerate Early Process Development
Thursday, May 22, 2014
New bioprocess webinar presents validation data on ambr15 microbioreactors from a major CMO.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 903
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv